BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18704638)

  • 1. Recurrent rectal GIST resected successfully after preoperative chemotherapy with imatinib mesylate.
    Hamada M; Ozaki K; Horimi T; Tsuji A; Nasu Y; Iwata J; Nagata Y
    Int J Clin Oncol; 2008 Aug; 13(4):355-60. PubMed ID: 18704638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of neoadjuvant imatinib mesylate therapy in sphincter-preserving procedures for anorectal gastrointestinal stromal tumor.
    Wang JP; Wang T; Huang MJ; Wang L; Kang L; Wu XJ
    Am J Clin Oncol; 2011 Jun; 34(3):314-6. PubMed ID: 20622646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of rectal gastrointestinal stromal tumor (GIST) locally resected after long-term chemotherapy with imatinib mesylate].
    Tonooka T; Takiguchi N; Yamamoto H; Nabeya Y; Ikeda A; Kainuma O; Souda H; Cho A; Muto Y; Yanagibashi H; Takano E; Denda T; Nagata M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1849-51. PubMed ID: 25731351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of rectal GIST treated with imatinib mesylate neoadjuvant therapy to preserve the anus].
    Sekoguchi S; Okuyama Y; Enoki Y; Kawakami T; Tomie A; Yamada N; Yoriki H; Fukui A; Hattori T; Kamata K; Tomatsuri N; Nakamura H; Sato H; Kimura H; Yoshida N; Shioaki Y; Fujimoto S
    Nihon Shokakibyo Gakkai Zasshi; 2009 Dec; 106(12):1751-7. PubMed ID: 19966517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Two cases of surgical resection of rectal gastrointestinal stromal tumor after neoadjuvant therapy with imatinib mesylate].
    Nakashima S; Fujita Y; Matsuo H; Ariyoshi Y; Fukuda K; Fujiyama J; Masuyama M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1932-4. PubMed ID: 23267934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectum.
    Fujimoto Y; Akiyoshi T; Konishi T; Nagayama S; Fukunaga Y; Ueno M
    Int J Colorectal Dis; 2014 Jan; 29(1):111-6. PubMed ID: 24018650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of rectal GIST treated by perineal partial rectal resection using laparoscopic surgery].
    Babaya A; Nakata K; Fukunaga M; Hoshino H; Kawabata R; Yamamoto T; Kawase T; Kimura Y; Ohzato H
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1846-8. PubMed ID: 25731350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term follow-up of the imatinib mesylate treatment for the patients with recurrent gastrointestinal stromal tumor (GIST): the liver metastasis and the outcome.
    Zhu J; Yang Y; Zhou L; Jiang M; Hou M
    BMC Cancer; 2010 May; 10():199. PubMed ID: 20465813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case with a lower rectal gastrointestinal stromal tumor undergoing sphincter-preserving laparoscopic resection after neoadjuvant imatinib therapy].
    Ide Y; Tokuoka M; Takeda M; Toshiyama R; Matsuyama J; Hashimoto K; Yokoyama S; Morimoto T; Fukushima Y; Nomura T; Kodama K; Takeda M; Sasaki Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1930-2. PubMed ID: 24393969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete remission of recurrent gastrointestinal stromal tumors after treatment with imatinib: report of a case.
    Kobayashi M; Okamoto K; Nakatani H; Okabayashi T; Namikawa T; Ichikawa K; Kitagawa H; Araki K
    Surg Today; 2006; 36(8):727-32. PubMed ID: 16865518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of a giant rectal gastrointestinal stromal tumor radically resectable after treatment with neoadjuvant imatinib mesylate].
    Sassa M; Kobayashi Y; Sugeno H; Iwadate M; Suzuki S; Endo Y; Nakamura I; Ohki S; Takenoshita S
    Gan To Kagaku Ryoho; 2013 Jul; 40(7):937-41. PubMed ID: 23863741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor.
    Shen C; Chen H; Yin Y; Chen J; Zhang B; Chen Z; Chen J
    Clinics (Sao Paulo); 2014 Nov; 69(11):758-62. PubMed ID: 25518034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal stromal tumors: imatinib and beyond.
    Schnadig ID; Blanke CD
    Curr Treat Options Oncol; 2006 Nov; 7(6):427-37. PubMed ID: 17032555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic resection of a gastrointestinal stromal tumor of the rectum after treatment with imatinib mesylate: report of a case.
    Nakamura T; Mitomi H; Onozato W; Sato T; Ikeda A; Naito M; Ogura N; Kamata H; Ooki A; Watanabe M
    Surg Today; 2012 Nov; 42(11):1096-9. PubMed ID: 22294424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is imatinib justified as an adjuvant chemotherapy for patients with recurrent gastrointestinal stromal tumors.
    Lai IR; Hu RH; Chang KJ
    Hepatogastroenterology; 2005; 52(63):826-8. PubMed ID: 15966213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor.
    Hou YY; Zhou Y; Lu SH; Qi WD; Xu C; Hou J; Tan YS
    World J Gastroenterol; 2009 Apr; 15(15):1910-3. PubMed ID: 19370794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphincter sparing resection of a large obstructive distal rectal gastrointestinal stromal tumour after neoadjuvant therapy with imatinib (Glivec).
    Kramp KH; Omer MG; Schoffski P; d'Hoore A
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25572603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in therapy for gastrointestinal stromal tumors.
    Maki RG
    Curr Oncol Rep; 2007 May; 9(3):165-9. PubMed ID: 17430686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant imatinib in a gastrointestinal stromal tumor of the rectum: report of a case.
    Ebihara Y; Okushiba S; Kawarada Y; Kitashiro S; Katoh H; Kondo S
    Surg Today; 2008; 38(2):174-7. PubMed ID: 18239881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib.
    Jakob J; Mussi C; Ronellenfitsch U; Wardelmann E; Negri T; Gronchi A; Hohenberger P
    Ann Surg Oncol; 2013 Feb; 20(2):586-92. PubMed ID: 22965573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.